Analysts Upgrade MSFT, CAT, GOOG and More Today, Unveiling Fresh Opportunities

 TopRated
 
  TopRated
 
Follow  Message
 
 
 
TopRatedStocks uncovering top-rated companies. Providing quick insights and recommendations, they help investors discover high-potential stocks based on robust metrics.
 

•  09 Jul 2025
 

Canaccord Genuity lifted its price target on Atai Life Sciences to $12 while maintaining a Buy rating, signaling confidence in its psychedelic therapies pipeline. With shares trading at $2.67, the upside potential here remains meaningful for high-risk, high-reward biotech investors looking for early-stage growth.

Best Buy received a rating upgrade on improved tariff management and a constructive growth outlook. While shares are near $72, the call suggests analysts see stabilization and potential for operational upside despite macro headwinds.

TopBuild caught attention after its acquisition of Progressive Roofing, with Benchmark reiterating its Buy rating. The stock jumped 5% to $374, reflecting the market’s confidence in management’s strategic expansion in the building materials and services space.

Caterpillar received an upgrade from Melius, citing data center power potential as a growth catalyst. At $403, this industrial giant looks poised to benefit from the AI infrastructure build-out while maintaining strong cyclical leverage.

Charles River Labs saw an upgrade from Citi, focusing on DSA growth prospects. Trading at $158, the upgrade points to optimism around its contract research services amid rising biopharma demand.

Datadog joined the S&P 500, and TD Cowen reiterated its Buy rating, reflecting its continued leadership in cloud monitoring. Shares recently dipped to $142, presenting a possible entry point as large-cap flows begin to follow the index inclusion.

Citi reiterated its Buy recommendation on Devon Energy, maintaining a bullish stance despite recent weakness. At $34, the call indicates confidence in the company’s shareholder return policy and operational efficiency.

UBS kept its Buy rating on EOG Resources with a $140 price target, underscoring its strong balance sheet and disciplined capital approach, with shares currently at $121.

Enterprise Products Partners maintained its Buy rating from UBS, reflecting confidence in stable cash flows and yield for income-focused investors, with shares at $31.

TD Cowen raised its price target on Genpact while maintaining a Buy rating, showing conviction in its digital transformation positioning, though the stock slipped to $45.

Alphabet saw analysts declare its growth catalysts as overly discounted, urging a “double-down” Strong Buy stance. Trading at $177, the call suggests a view that the AI and ad rebound narrative remains underappreciated.

Wolfe Research upgraded Huntington Bancshares to Outperform, citing stabilizing regional banking trends. At $17, the upgrade suggests selective optimism in the battered regional bank space.

Citi upgraded Hologic to Buy, highlighting attractive valuation and a favorable growth outlook in medical diagnostics, with shares at $65.

LiveOne rallied 4% to $0.80 after Slacker Radio partnered with Intuizi to enhance subscriber targeting, a strategic move aiming to fuel subscriber growth and engagement.

Merck retained a Buy rating from UBS, underpinned by optimism around HPV vaccine prospects. Shares rose 3% to $83, reflecting ongoing interest in its robust pipeline.

Microsoft received a string of upgrades from Oppenheimer, which noted that the AI opportunity remains underpriced. Shares at $502 still imply further upside as Wall Street re-evaluates its AI and cloud positioning.

Roku maintained a Buy rating at Needham with an upgraded price target, as its labor efficiency improvements support margin expansion. Shares at $88 show continued investor interest in its turnaround.

SharpLink Gaming was reiterated as a Buy, driven by Ethereum exposure, which analysts believe adds strategic value to its gaming operations, with shares at $16.

Seaport Global raised its price target on Synchrony Financial while maintaining a Buy rating, pointing to a solid consumer credit backdrop and attractive valuation with shares at $69.

Thermo Fisher Scientific, despite some conflicting analyst sentiment, saw support on growth stability with shares trading at $416, indicating a potential rebound for patient investors.

Westinghouse Air Brake (Wabtec) maintained its Buy rating at BofA, supported by operational execution and a raised price target. At $212, the stock continues to benefit from transport sector tailwinds.

Wingstop initiated coverage with a Buy rating, reflecting analysts' confidence in its growth trajectory and store expansion strategy, with shares rising to $333.

Warner Music was upgraded to Neutral by BofA, reflecting its cost-cutting and JV initiatives, with shares at $29 showing cautious optimism for gradual improvement in the music industry’s margin profile.